Skip to main content
. 2025 Jul 29;17(7):4681–4688. doi: 10.21037/jtd-24-1821

Table 1. Comparison of demographic data, comorbidities, clinical symptoms, and blood gas analysis parameters among different risk stratifications.

Characteristics Low-risk and intermediate-low-risk (n=196) Intermediate-high-risk and high-risk (n=31) P
Demographic characteristics
   Gender 0.16
    Male 96 (49.0) 11 (35.5)
    Female 100 (51.0) 20 (64.5)
   Age, years 68 (61, 76) 72 (64, 76) 0.28
Comorbidities
   Hypertension 88 (44.9) 12 (38.7) 0.52
   Diabetes 38 (19.4) 5 (16.1) 0.67
   Cancer 39 (19.9) 4 (12.9) 0.36
   Rheumatic immune system diseases 14 (7.1) 3 (9.7) 0.62
   Chronic pulmonary diseases 29 (14.8) 2 (6.5) 0.21
   Chronic heart failure/atrial fibrillation 12 (6.1) 2 (6.5) 0.94
   Recent surgery 26 (13.3) 5 (16.1) 0.67
   Thrombophilia 12 (6.1) 3 (9.7) 0.46
   Deep vein thrombosis 156 (79.6) 23 (74.2) 0.47
Symptoms
   Cough 66 (33.7) 7 (22.6) 0.22
   Expectoration 52 (26.5) 6 (19.4) 0.40
   Chest pain 52 (26.5) 9 (29.0) 0.77
   Dyspnea 115 (58.7) 27 (87.1) 0.002
   Hemoptysis 21 (10.7) 2 (6.5) 0.47
   Syncope 15 (7.7) 7 (22.6) 0.009
   Palpitations 21 (10.7) 4 (12.9) 0.72
   Fever 29 (14.8) 0 (0.0) 0.03
Blood gas analysis indicators
   P/F ratio 311.6 (267.7, 375.4) 227 (185.5, 270) <0.001
   PaCO2 37.5 (34.9, 41.7) 37.4 (32.5, 39.0) <0.001
   SpO2/FiO2 404 (295.2, 457) 278.0 (232, 352) 0.002

Data are presented as n (%) or median (interquartile range). P/F, partial oxygen pressure/fraction of inspired oxygen; PaCO2, partial pressure of carbon dioxide; SpO2/FiO2, pulse oxygen saturation/fraction of inspired oxygen.